Picture of Wave Life Sciences logo

WVE — Wave Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Brief: Wave Life Sciences Plans To Have Five Galnac-RNA Editing Or GalNAc-siRNA Programs In Clinic By 2026

Oct 30 (Reuters) - WAVE Life Sciences Ltd  WVE.O :
    * WAVE LIFE SCIENCES LTD: PLANS TO HAVE FIVE GALNAC-RNA
EDITING OR
GALNAC-SIRNA PROGRAMS IN CLINIC BY 2026
    * WAVE LIFE SCIENCES LTD: WVE-007 (INHBE GALNAC-SIRNA FOR
OBESITY)
IS ON TRACK TO INITIATE A CLINICAL TRIAL IN 1Q 2025
    * WAVE LIFE SCIENCES: NEW PRECLINICAL DATA IN DIET INDUCED
OBESE
(DIO) MICE DEMONSTRATE POTENTIAL OF WVE-007 TO BE USED ACROSS
TREATMENT CONTINUUM

Source text:  ID:nGNX9pk720 
Further company coverage:  WVE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Wave Life Sciences

See all news